A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent
Rademaker-Lakhai, J. M.Volume:
10
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-03-0746
Date:
June, 2004
File:
PDF, 177 KB
english, 2004